Literature DB >> 26405204

Utility of Screening for Cerebral Vasospasm Using Digital Subtraction Angiography.

Eric J Arias1, Sravya Vajapey2, Matthew R Reynolds2, Michael R Chicoine2, Keith M Rich2, Ralph G Dacey2, Ian G Dorward2, Colin P Derdeyn2, Christopher J Moran2, DeWitte T Cross2, Gregory J Zipfel2, Rajat Dhar2.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral arterial vasospasm (CVS) is a common complication of aneurysmal subarachnoid hemorrhage strongly associated with neurological deterioration and delayed cerebral ischemia (DCI). The utility of screening for CVS as a surrogate for early detection of DCI, especially in patients without clinical signs of DCI, remains uncertain.
METHODS: We performed a retrospective analysis of 116 aneurysmal subarachnoid hemorrhage patients who underwent screening digital subtraction angiography to determine the association of significant CVS and subsequent development of DCI. Patients were stratified into 3 groups: (1) no symptoms of DCI before screening, (2) ≥1 episodes of suspected DCI symptoms before screening, and (3) unable to detect symptoms because of poor examination.
RESULTS: Patients asymptomatic before screening had significantly lower rates of CVS (18%) compared with those with transient symptoms of DCI (60%; P<0.0001). None of the 79 asymptomatic patients developed DCI after screening, regardless of digital subtraction angiography findings, compared with 56% of those with symptoms (P<0.0001). Presence of CVS was significantly associated with DCI in those with transient symptoms and in those whose examinations did not permit clear assessment (odds ratio 16.0, 95% confidence interval 2.2-118.3, P=0.003).
CONCLUSIONS: Patients asymptomatic before screening have low rates of CVS and seem to be at negligible risk of developing DCI. Routine screening of asymptomatic patients seems to have little utility. Screening may still be considered in patients with possible symptoms of DCI or those with examinations too poor to clinically detect symptoms because finding CVS may be useful for risk stratification and guiding management.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  cerebral vasospasm; delayed cerebral ischemia; digital subtraction angiography; screening; subarachnoid hemorrhage

Mesh:

Year:  2015        PMID: 26405204      PMCID: PMC4624568          DOI: 10.1161/STROKEAHA.115.010081

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  15 in total

1.  Effect of intraarterial papaverine and/or angioplasty on the cerebral veins in patients with vasospasm after subarachnoid hemorrhage due to ruptured intracranial aneurysms.

Authors:  Ayman A Elsayed; Christopher J Moran; DeWitte T Cross; Colin P Derdeyn; Thomas K Pilgram; James M Milburn; Ralph G Dacey; Michael N Diringer
Journal:  Neurosurg Focus       Date:  2006-09-15       Impact factor: 4.047

Review 2.  Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.

Authors:  Joshua B Bederson; E Sander Connolly; H Hunt Batjer; Ralph G Dacey; Jacques E Dion; Michael N Diringer; John E Duldner; Robert E Harbaugh; Aman B Patel; Robert H Rosenwasser
Journal:  Stroke       Date:  2009-01-22       Impact factor: 7.914

3.  The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results.

Authors:  N F Kassell; J C Torner; E C Haley; J A Jane; H P Adams; G L Kongable
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

4.  Surgical risk as related to time of intervention in the repair of intracranial aneurysms.

Authors:  W E Hunt; R M Hess
Journal:  J Neurosurg       Date:  1968-01       Impact factor: 5.115

5.  Transcranial Doppler versus angiography in patients with vasospasm due to a ruptured cerebral aneurysm: A systematic review.

Authors:  C Lysakowski; B Walder; M C Costanza; M R Tramèr
Journal:  Stroke       Date:  2001-10       Impact factor: 7.914

6.  Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group.

Authors:  Mervyn D I Vergouwen; Marinus Vermeulen; Jan van Gijn; Gabriel J E Rinkel; Eelco F Wijdicks; J Paul Muizelaar; A David Mendelow; Seppo Juvela; Howard Yonas; Karel G Terbrugge; R Loch Macdonald; Michael N Diringer; Joseph P Broderick; Jens P Dreier; Yvo B W E M Roos
Journal:  Stroke       Date:  2010-08-26       Impact factor: 7.914

7.  Clinical utility of multislice computed tomographic angiography for detection of cerebral vasospasm in acute subarachnoid hemorrhage.

Authors:  S P Joo; T S Kim; Y S Kim; K S Moon; J K Lee; J H Kim; S H Kim
Journal:  Minim Invasive Neurosurg       Date:  2006-10

8.  Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  M A Sloan; A V Alexandrov; C H Tegeler; M P Spencer; L R Caplan; E Feldmann; L R Wechsler; D W Newell; C R Gomez; V L Babikian; D Lefkowitz; R S Goldman; C Armon; C Y Hsu; D S Goodin
Journal:  Neurology       Date:  2004-05-11       Impact factor: 9.910

9.  A randomized trial of nicardipine in subarachnoid hemorrhage: angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study.

Authors:  E C Haley; N F Kassell; J C Torner
Journal:  J Neurosurg       Date:  1993-04       Impact factor: 5.115

10.  Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.

Authors:  C M Fisher; J P Kistler; J M Davis
Journal:  Neurosurgery       Date:  1980-01       Impact factor: 4.654

View more
  7 in total

1.  Assessing Contribution of Higher Order Clinical Risk Factors to Prediction of Outcome in Aneurysmal Subarachnoid Hemorrhage Patients.

Authors:  Azade Tabaie; Shamim Nemati; Jason W Allen; Charlotte Chung; Flavia Queiroga; Won-Jun Kuk; Adam B Prater
Journal:  AMIA Annu Symp Proc       Date:  2020-03-04

2.  Prediction of Delayed Cerebral Ischemia with Cerebral Angiography: A Meta-Analysis.

Authors:  Gyanendra Kumar; Oana M Dumitrascu; Chia-Chun Chiang; Cumara B O'Carroll; Andrei V Alexandrov
Journal:  Neurocrit Care       Date:  2019-02       Impact factor: 3.210

Review 3.  Microvascular platelet aggregation and thrombosis after subarachnoid hemorrhage: A review and synthesis.

Authors:  Julian V Clarke; Julia M Suggs; Deepti Diwan; Jin V Lee; Kim Lipsey; Ananth K Vellimana; Gregory J Zipfel
Journal:  J Cereb Blood Flow Metab       Date:  2020-04-28       Impact factor: 6.200

Review 4.  Research progress of imaging technologies for ischemic cerebrovascular diseases.

Authors:  Li Chen; Ningning Zhao; Shan Xu
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

5.  Vasospasm-Related Death after Aneurysmal Subarachnoid Hemorrhage: A Retrospective Case-Control Study.

Authors:  Ali Khanafer; Pervinder Bhogal; Victoria Hellstern; Christoph Harmening; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

6.  Intracranial stenting as a bail-out option for posthemorrhagic cerebral vasospasm: a single-center experience with long-term follow-up.

Authors:  Ali Khanafer; Alexandru Cimpoca; Pervinder Bhogal; Hansjörg Bäzner; Oliver Ganslandt; Hans Henkes
Journal:  BMC Neurol       Date:  2022-09-15       Impact factor: 2.903

7.  The feasibility of non-contrast-enhanced zero echo time magnetic resonance angiography for characterization of intracranial atherosclerotic disease.

Authors:  Chao Zhang; Weiqiang Dou; Ke Yu; Yun Ji; Wenliang Wang; Muhammad Umair Sami; Yong Shen; Kai Xu
Journal:  Quant Imaging Med Surg       Date:  2021-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.